Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2011 Mar 15;52(6):726–735. doi: 10.1093/cid/ciq245

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

PMC Copyright notice

Figure 2. — Improvement in survival over time. Five-year survival is depicted for all patients (first row), responders to immunosuppressive therapy (IST) (second row), and non-responders to IST (third row). Six-month survival, as a surrogate for neutropenia, in non-responders to IST is presented in the fourth row. The first column depicts hematopoietic stem cell transplantation (HSCT)–censored Kaplan-Meier survival curves and the second column HSCT non-censored curves. Overall survival for all patients was improved in group 3 (first row) compared with groups 1 and 2. Among responders to immunosuppressive therapy, no difference in survival was noted over time (second row). Among non-responders, a marked improvement in survival occurred in group 3, compared with survival in groups 1 and 2 (third row). The 6-month survival after IST among non-responders was also markedly higher in group 1 than in group 3 (fourth row).